New Cancer Drug Illustrates Ineffectiveness of Mainstream Cancer Treatment

by Tony Isaacs

(The Truth About Cancer) Mainstream medicine and drug maker Bristol-Myers Squibb (BMS) are touting BMS’s new cancer drug Opdivo (nivolumab) as a “breakthrough” that offers the hope of longer life. A closer look reveals just how cruel and deceptive such claims are and how the new drug, rather than being a new breakthrough, is just one more example of mainstream medicine’s false promises and an indictment of the mainstream medicine’s failure in treating cancer. Read More:

See also:

"Dying cancer patients are being milked of every last dollar"

"Can You Believe an Oncologist When He Says You Need Chemotherapy?"

"Does Chemo & Radiation Actually Make Cancer More Malignant?"